The Trump administration has said lower drug prices would be a legislative priority.   The nation’s leading hospital and doctors’ groups also spoke against the bill. The American Medical Association wrote (PDF) in a letter to House committee leaders that it could not support the bill because of the "expected decline in health insurance coverage and the potential harm it would cause to vulnerable patient populations. " 